Nifedipine for the Maintenance Tocolysis of Preterm Labor: Comparison to Placebo in a Prospective, Randomized, Double Blind Trial

Comparing nifedipine to placebo for the maintenance tocolysis of preterm...

Date First Received: September 12, 2005

Last Updated: March 21, 2008

Verified by: Stanford University, March 2008

Clinical Trial Phase: N/A | Start Date: November 2001

Overall Status: Completed

Estimated Enrollment: 0

Brief Summary

Official Title: “Nifedipine for the Maintenance Tocolysis of Preterm Labor: Comparison to Placebo in a Prospective, Randomized Double Blind Trial”

Condition Keyword(s):

Intervention(s):

Comparing nifedipine to placebo for the maintenance tocolysis of preterm labor

Study Type: Interventional

Study Design: Treatment, Randomized, Double-Blind, Placebo Control, Single Group Assignment

Intervention(s) in this Clinical Trial

  • Drug: nifedipine

Outcome Measures for this Clinical Trial

Primary Measures

  • Achieving 37 weeks gestation

Secondary Measures

  • Incidence of recurrent preterm labor
  • Neonatal outcomes

Criteria for Participation in this Clinical Trial

Inclusion Criteria:

  • arrested preterm labor

Exclusion Criteria:

  • ruptured membranes
  • fetal distress
  • placenta previa
  • placental abruption
  • maternal medical contraindication to tocolysis

Gender Eligibility for this Clinical Trial: Female

Minimum Age for this Clinical Trial: 18 Years

Maximum Age for this Clinical Trial: N/A

Are Healthy Volunteers Accepted for this Clinical Trial?: No

Clinical Trial Sponsor Information

Lead Sponsor: Stanford University

Overall Clinical Trial Officials and Contacts

Yasser Yehia El-Sayed Principal Investigator Stanford University  

Additional Information

Information obtained from ClinicalTrials.gov on December 03, 2008

Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00185952

Study ID Number: 76251

ClinicalTrials.gov Identifier: NCT00185952

Health Authority: United States: Institutional Review Board

Clinical Trials Authorship and Review

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.